Comparative efficacy of oltipraz (1 dose, 30 mg/kg) and the combination of niridazole (25 mg/kg) and metrifonate (10 mg/kg) against S. haematobium
Abstract
PUGH (1978) and TEEDSALE et al. (1980) showed that an associated single dose of metrifonate (12.5 mg/kg) plus niridazole (25 mg/kg) gave good results on Schistosoma haematobium: the egg-reduction percentage ranged between 84.7 and 91.2. In Niger, we compared the effects of this medication to oltipraz in a single dose (30 mg/kg). We selected a dosage of 10 mg/kg of metrifonate and 25 mg/kg of niridazole. This trial was carried out during the minimal transmission period. --109 adults (greater than 15 years) received oltipraz and 159 this combined treatment. They were examined twice: 11/2 month and 6 months after treatment. At the first control, the cure rate was 26.7% for oltipraz and 23.3% for the combined treatment, the egg-reduction was respectively 77.1% and 41.3%. Six months after treatment, the cure rate was 43.5% for oltipraz and 27.7% for the combined treatment and the egg-reduction was 66.5% and 2.0% respectively. Following these results, the authors recommend against the combined treatment in Niger. They note that if, in some particular conditions, this medication can give good results (PUGH, 1978, TEESDALE et al., 1980) it is however necessary to include its test in future control projects. Also, they note the weak result obtained with oltipraz; but, in this case, the heavy endemic level and high egg-loads might explain it, as well as the fact that the 30 mg/kg dosage was probably insufficient.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 109 participants or records.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.